DelveInsight’s, “ Small Lymphocytic Lymphoma Pipeline Insight, 2025 ” report provides comprehensive insights about 80+ ...

DelveInsight’s, “Diabetes Pipeline Insight 2025” report provides comprehensive insights about 200+ companies and 200+ ...

The return of a policy towards US energy independence is charging up the oil and gas production sector, which will benefit ...

Pfizer Inc. (NYSE: PFE) announced today the completion of a global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK) ...

Pipelines are the critical infrastructure that underpins global energy trade and geopolitical power, and these nine projects ...

The Boston Bruins' once-dormant prospect pipeline is getting stronger with the arrival of James Hagens and other blue-chip ...

Group net sales grow by 6.3%* to EUR 14.0 billion, driven by Human Pharma (EUR 11.3 billion) and Animal Health (EUR 2.6 billion)Regulatory submissions underway for zongertinib and nerandomilast, with ...

Roche Holding AG's H2 2025 earnings show solid growth in pharma revenues but highlight pipeline struggles and U.S. pricing pressures. Click for my RHHBY update.

Amylyx is a high-risk biotech targeting rare diseases with strong cash reserves. Key trials soon may drive a 40% stock upside.

A strong technology backbone also enables the growing importance of GCCs in product ownership. Embracing cloud-based ...

Innovation has long been the heartbeat of lululemon athletica inc.’s LULU brand identity. From redefining athleisure with ...

Operating expenses declined 28%, reducing net loss to $21.5 million (GAAP). Record backlog reached $12.5 million, up 155 %, but management did not offer quantitative 2026 guidance.